N-11 TRUNCATED AMYLOID-BETA MONOCLONAL ANTIBODIES, COMPOSITIONS, METHODS AND USES
This invention relates to antibodies, including specified portions or variants, specific for at least the human Amyloid-beta 11 N-terminal site, i.e. A.szlig.11-x peptides. It further provides methods of making and using said antibodies, including therapeutic formulations, administration and devices...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French |
Published |
12.02.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This invention relates to antibodies, including specified portions or variants, specific for at least the human Amyloid-beta 11 N-terminal site, i.e. A.szlig.11-x peptides. It further provides methods of making and using said antibodies, including therapeutic formulations, administration and devices.
L'invention concerne des anticorps, y compris des parties spécifiées ou des variantes génétiques, qui sont spécifiques au moins pour le site N-terminal bêta-amyloïde 11 humain, à savoir les peptides A.szlig.11-x. Elle concerne en outre des procédés de fabrication et d'utilisation de ces anticorps, y compris des formulations thérapeutiques, des modes d'administration et des dispositifs. |
---|---|
Bibliography: | Application Number: CA20032498058 |